Translation initiator EIF4G1 mutations in familial Parkinson disease.
暂无分享,去创建一个
Michael K. Hutchinson | P. Lockhart | A. Destée | M. Farrer | J. Kachergus | M. Hulihan | S. Lincoln | D. Maraganore | A. Bentivoglio | D. Dickson | N. Sonenberg | R. Uitti | T. Foroud | G. Opala | R. Gibson | Z. Wszolek | E. Valente | N. Pankratz | T. Lynch | R. Frigerio | A. Milnerwood | J. Aasly | O. Ross | É. Le Rhun | W. Nichols | A. Duflot | F. Leprêtre | A. Zubair | F. Hentati | C. Vilariño-Güell | A. Soto-Ortolaza | S. A. Cobb | B. Keeling | J. Dachsel | A. Krygowska-Wajs | M. Chartier-Harlin | L. Tapia | K. Nishioka | A. Kreisler | E. Mutez | L. Larvor | C. Vanbesien-Mailliot | B. Behrouz | H. Melrose | D. Gosal | E. Hentati | L. Williams | M. Song | Akiko Yanagiya | Justin A. Bacon
[1] M. Farrer,et al. VPS35 mutations in Parkinson disease. , 2011, American journal of human genetics.
[2] J. Hardy,et al. Genetic Analysis of Pathways to Parkinson Disease , 2010, Neuron.
[3] N. Sokol,et al. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression , 2010, Nature.
[4] Thomas Gasser,et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.
[5] A. Whitworth,et al. Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss , 2009, Nature Neuroscience.
[6] H. Büeler. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease , 2009, Experimental Neurology.
[7] P. Greengard,et al. Inhibition of mTOR Signaling in Parkinson’s Disease Prevents l-DOPA–Induced Dyskinesia , 2009, Science Signaling.
[8] H. Braak,et al. Parkinson's Disease , 2009, Annals of the New York Academy of Sciences.
[9] P. Levine,et al. Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer , 2009, Nature Cell Biology.
[10] J. Blenis,et al. Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.
[11] A. Hinnebusch,et al. Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.
[12] N. Sonenberg,et al. Requirement of RNA Binding of Mammalian Eukaryotic Translation Initiation Factor 4GI (eIF4GI) for Efficient Interaction of eIF4E with the mRNA Cap , 2008, Molecular and Cellular Biology.
[13] S. Przedborski,et al. Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.
[14] J. Zavadil,et al. eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy , 2008, The Journal of cell biology.
[15] G. Scheper,et al. Translation matters: protein synthesis defects in inherited disease , 2007, Nature Reviews Genetics.
[16] M. Breteler,et al. Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.
[17] Aaron K. LeFebvre,et al. Translation Initiation Factor eIF4G-1 Binds to eIF3 through the eIF3e Subunit* , 2006, Journal of Biological Chemistry.
[18] Tara Cox Matise,et al. MAP-O-MAT: internet-based linkage mapping , 2005, Bioinform..
[19] J. Darlix,et al. Conducting the initiation of protein synthesis: the role of eIF4G , 2003, Biology of the cell.
[20] D E Weeks,et al. Multipoint Estimation of Identity-by-Descent Probabilities at Arbitrary Positions among Marker Loci on General Pedigrees , 2001, Human Heredity.
[21] L. Defebvre,et al. Linkage exclusion in French families with probable Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[22] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[23] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[24] J. Ott. Computer-simulation methods in human linkage analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[25] S. Gilman,et al. Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.